|
|
Calendar & News > News
UK renal and Renal Association news
QOF '08: Proteinuria added to ACEi indication |
| Posted by Nephrite on Apr 09 2008 at 8:59 PM |
According to Dr Donal O'Donohue, the NHS (England) Clinical Director for Renal Services, it looks likely that proteinuria will be added to the Quality Outcomes Framework (QOF) for 2008-9. The QOF is the means by which General Practitioners (primary care physicians) receive extra remuneration for achieving specific performance targets. More info from the tsar's blog.
According to NHS Employers the wording of the new QOF Indicator is:
Chronic Kidney Disease
CKD4 becomes CKD5 – changes highlighted in bold CKD5: The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) (unless a contraindication or side effects are recorded) |
| Please report these diseases:
Familial membranous (see June 2005) Calciphylaxis (May 2003)Nephrogenic sclerosing dermopathy (June 2002, Nov 2006) Hyperuricaemic nephropathies (March 2006 newsletter) For older dates, go to older Renal Assoc news from the archives |